UOL PUBLISHING, INC.
_________ SHARES
COMMON STOCK
PURCHASE AGREEMENT
October ___, 1996
FRIEDMAN, BILLINGS, XXXXXX & CO., INC.
as Representative of the several Underwriters
Friedman, Billings, Xxxxxx & Co., Inc.
0000 Xxxxxxxxxx Xxxxxx Xxxxx
Xxxxxxxxx, Xxxxxxxx 00000
Dear Sirs:
UOL Publishing, Inc., a Delaware corporation (the "Company"), confirms its
agreement with Friedman, Billings, Xxxxxx & Co., Inc. ("FBR"), and each of the
other Underwriters named in Schedule A hereto (collectively, the "Underwriters,"
which term shall also include any underwriter substituted as provided in Section
9 hereof), for whom FBR is acting as Representative and is hereinafter referred
to as the "Representative", subject to the terms and conditions stated herein,
with respect to the sale by the Company to the Underwriters, acting severally
and not jointly, of _________ shares (the "Firm Shares") of the Company's Common
Stock, par value $0.01 per share (the "Common Stock"), as set forth in Schedule
A hereto, and with respect to the grant by the Company to the Underwriters of
the option described in Section 2(b) hereof to purchase all or any part of an
additional ________ shares of Common Stock (the "Option Shares") to cover
over-allotments. The Firm Shares and the Option Shares are collectively
hereinafter called the "Shares".
Prior to the purchase and public offering of the Shares by the Underwriters
("the Offering"), the Company, and the Representative, acting on behalf of the
Underwriters, shall enter into an agreement substantially in the form of Exhibit
A hereto (the "Pricing Agreement"). The Pricing Agreement may take the form of
an exchange of any standard form of written telecommunication between the
Company and the Representative and shall specify such applicable information as
is indicated in Exhibit A hereto. The offering of the Shares will be governed by
this Agreement, as supplemented by the Pricing Agreement. From and after the
date of the execution and delivery of the Pricing Agreement, this Agreement
shall be deemed to incorporate the Pricing Agreement.
The Company has prepared and filed with the Securities and Exchange
Commission (the "Commission") a registration statement on Form S-1 (No. 333____)
and a related preliminary prospectus for the registration of the Shares
1
under the Securities Act of 1933, as amended (the "1933 Act"), and has prepared
and filed such amendments thereto and such amended prospectuses as may have been
required to the date hereof, and will prepare and file such additional
amendments thereto and such amended prospectuses as may hereafter be required.
Each prospectus used before the time such prospectus is declared effective by
the Commission and prior to the date hereof shall be referred to as a
"Preliminary Prospectus." Such registration statement when it becomes effective
(as amended, if applicable) and the prospectus constituting a part thereof
(including in each case the information, if any, deemed to be a part thereof
pursuant to Rule 430A(b) of the rules and regulations under the 1933 Act (the
"1933 Act Regulations")), as from time to time amended or supplemented pursuant
to the 1933 Act or otherwise, are hereinafter referred to as the "Registration
Statement" and the "Prospectus," respectively, except that if any revised
prospectus shall be provided to the Underwriters by the Company for use in
connection with the offering of the Shares which differs from the Prospectus on
file at the Commission at the time the Registration Statement becomes effective
(whether or not such revised prospectus is required to be filed by the Company
pursuant to Rule 424(b) of the 1933 Act Regulations), the term "Prospectus"
shall refer to such revised prospectus from and after the time it is first
provided to the Underwriters for such use. The Company understands that the
Underwriters propose to make a public offering of the Shares as soon as the
Representative deems advisable after the Registration Statement becomes
effective and the Pricing Agreement has been executed and delivered.
I. Representations and Warranties of the Company
(a) The Company represents and warrants to, and agrees with, each
Underwriter as of the date hereof and as of the date of the Pricing Agreement
(such later date being hereinafter referred to as the "Representation Date") as
follows:
1. At the time the Registration Statement becomes effective and at the
Representation Date, the Registration Statement will comply in all
material respects with the requirements of the 1933 Act and the 1933
Act Regulations and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading, and the
Prospectus, at the Representation Date (unless the term "Prospectus"
refers to a prospectus that has been provided to the Underwriters by
the Company for use in connection with the offering of the Shares
which differs from the Prospectus on file at the Commission at the
time the Registration Statement becomes effective, in which case at
the same time it is first provided to the Underwriters for such use)
and at the Closing Time referred to in Section 2(c) hereof, will
comply in all material respects with the requirements of the 1933 Act
and the 1933 Act Regulations and will not contain an untrue statement
of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading.
2. No stop order suspending the effectiveness of the Registration
Statement or any part thereof has been issued and no proceeding for
that purpose has been instituted or, to the knowledge of the Company,
threatened by the Commission or by the state securities authority of
any jurisdiction. No order preventing or suspending the use of the
Prospectus has been issued and
2
no proceeding for that purpose has been instituted or, to the
knowledge of the Company, threatened by the Commission or by the state
securities authority of any jurisdiction.
3. Ernst & Young LLP, who have certified the financial statements and
financial statement schedules included in the Registration Statement,
are and were at all relevant times, with respect to the Company,
independent public accountants within the meaning of Rule 101 of the
Code of Professional Conduct of the American Institute of Certified
Public Accountants and as required by the 1933 Act and the 1933 Act
Regulations.
4. The financial statements (including the notes thereto) included in the
Registration Statement, any Preliminary Prospectus and the Prospectus
comply in all material respects with the requirements of the Rules and
Regulations and present fairly the financial position of the Company
and its consolidated Subsidiaries, at the dates indicated and the
results of their operations for the periods specified, and except as
otherwise stated in the Registration Statement, such financial
statements have been prepared in conformity with generally accepted
accounting principles applied on a consistent basis. The financial
statement schedules included in the Registration Statement presents
fairly the information required to be stated therein. The financial
information and data included in the Registration Statement and the
Prospectus conform in all material respects with the requirements of
the 1983 Act and the 1933 Act Regulations and present fairly the
information included therein and have been prepared on a basis
consistent with that of the financial statements included in the
Registration Statement and the Prospectus and the books and records of
the Company and its consolidated subsidiaries, as presented therein.
Other than the historical financial statements (and schedules)
included therein, no other historical or pro forma financial
statements (or schedules) are required by the 1933 Act or the 1933 Act
Regulations to be included in the Registration Statement. Except as
reflected or disclosed in the financial statements included in the
Registration Statement of otherwise set forth in the Prospectus,
neither the Company, nor any of the Subsidiaries, is subject to any
material indebtedness, obligation, or liability, contingent or
otherwise known to the Company.
5. Since the latest respective dates as of which information is given in
the Registration Statement and the Prospectus, except as otherwise
stated therein, (A) there has been no material adverse change in the
condition, financial or otherwise, or in the earnings, assets,
business affairs or business prospects of the Company, of the
Subsidiaries (as defined below) considered as a single enterprise,
whether or not arising in the ordinary course of business, (B) there
have been no acquisitions or other transactions entered into by the
Company, or any subsidiary that are material with respect to such
entities, considered as a single enterprise, or would result in any
inaccuracy
3
in the representations contained in Section 1(a)(iv) above (C) there
has been no dividend or distribution of any kind declared, paid, or
made by the Company on any class of its capital stock (D) there has
been no change in the capital stock of the Company or any Subsidiary,
(E) there has been no increase in the indebtedness of the Company, or
any Subsidiary and (F) there have been no transactions entered into by
the Company which are material to the Company, other than those in the
ordinary course of business.
6. The Company has been duly organized and is validly existing as a
corporation in good standing under the laws of the State of Delaware,
with corporate power and authority to own, lease and operate its
properties, conduct its business as described in the Prospectus and to
enter into and perform its obligations under this Agreement. The
Company is duly qualified as a foreign corporation for the transaction
of business and is in good standing under the laws of each other
jurisdiction in which such qualification is required, except where the
failure to so qualify would not have a material adverse effect on the
condition, financial or otherwise, or the earnings, assets, business
affairs or business prospects of the Company, or the Subsidiaries,
considered as a single enterprise.
7. Each subsidiary of the Company ("Subsidiary") has been duly
incorporated and is validly existing as a corporation in good standing
under the laws of the jurisdiction of its incorporation, has corporate
power and authority to own, lease and operate its properties and to
conduct its business as described in the Prospectus and is duly
qualified as a foreign corporation to transact business and is in good
standing in each jurisdiction under the laws of such jurisdiction in
which such qualification is required, except where the failure to so
qualify would not have a material adverse effect on the condition,
financial or otherwise, or the earnings, assets, business affairs or
business prospects of the Company and its subsidiaries considered as
one enterprise; all of the issued and outstanding capital stock of
each Subsidiary has been duly authorized and validly issued, is fully
paid and non-assessable and is owned by the Company, directly or
through subsidiaries, free and clear of any security interest,
mortgage, pledge, lien, encumbrance, claim or equity.
8. The authorized, issued and outstanding Capital Stock and any
short-term debt and Capital lease obligations of the Company conform
in all material respects to all statements relating thereto contained
in the Prospectus. All such shares of Common Stock, Series A Preferred
Stock and Series B Preferred Stock have been duly and validly
authorized and issued, are fully paid and non-assessable, are not
subject to preemptive or other rights, and have been offered and sold
in compliance with all applicable laws (including federal and state
securities laws). No shares of capital stock of the Company are
reserved for any purpose except in connection with (i) the stock
4
option plans of the Company as described in the Prospectus, (ii) the
issuance of Common Stock upon the exercise of warrants to subscribe
for shares of Common Stock as described in the Prospectus. Except as
described in the Prospectus, there are no outstanding securities
convertible into or exchangeable for any capital stock of the Company
and no outstanding options, rights (preemptive or otherwise) or
warrants to purchase or to subscribe for such shares or any other
securities of the Company.
9. The Shares to be issued and sold by the Company to the Underwriters
hereunder have been duly and validly authorized and reserved for
issuance and sale to the Underwriters pursuant to this Agreement by
all necessary corporate action on the part of the Company, and when
issued and delivered by the Company pursuant to this Agreement against
payment of the consideration set forth in the Pricing Agreement, will
be duly and validly issued and fully paid and non-assessable. The
terms of the Shares conform to all statements and descriptions related
thereto contained in the Prospectus and comply with all applicable
legal requirements. The issuance of the Shares is not subject to
preemptive or other rights. The Shares conform to the provisions of
the Charter (as defined below). The form of share certificate to be
used to evidence the Shares is in due and proper form and complies
with all applicable legal requirements.
10. Neither the Company nor any Subsidiary is in violation of its charter
or by-laws (the "Charter"). Neither the Company nor any Subsidiary is
in default in the performance or observance of any obligation,
agreement, covenant. or condition contained in any contract,
indenture, mortgage, deed of trust, loan agreement, note, lease or
other agreement or instrument to which the Company, or any Subsidiary
is, or at the Closing Time will be, a party or by which the Company or
any Subsidiary is, or at the Closing Time will be, bound or to which
any of the property or assets of the Company or any Subsidiary is, or
at the Closing Time will be, subject, except where a default there
under would not have a material adverse effect on the condition,
financial or otherwise, or the earnings, assets, or business affairs
of the Company, and the Subsidiaries, considered as a single
enterprise.
11. (A) This Agreement has been duly authorized, executed, and delivered
by the Company, and is a valid and binding agreement of the Company,
enforceable against the Company, in accordance with its terms; and (B)
at the Representation Date, the Pricing Agreement will have been duly
authorized, executed, and delivered by the Company and will be a valid
and binding agreement of the Company, enforceable against the Company
in accordance with its terms.
12. The issuance and sale of the Firm Shares and the Option Shares by the
Company, the performance by the Company of its obligations under this
Agreement, the Pricing Agreement, and the consummation of the
5
transactions herein and therein contemplated, including the
application of the net proceeds from the sale of the Firm Shares and
the Option Shares as described in the Prospectus will not (A) conflict
with or result in a breach or violation of any of the terms or
provisions of, constitute a default under, or result in the
acceleration of the maturity of any indebtedness under, any contract,
indenture, mortgage, deed of trust, loan agreement or other agreement
or instrument to which the Company or any Subsidiary is a party or by
which the Company or any Subsidiary is bound or to which any of the
property or assets of the Company or any Subsidiary is subject, or (B)
result in any violation of the provisions of the certificate of
incorporation or by-laws of the Company or any Subsidiary, or any
statute or any order, rule or regulation of any court or governmental
agency or body having jurisdiction over the Company or any Subsidiary
or any of their respective properties.
13. Except to the extent obtained prior to the Closing Time, no consent,
approval, authorization, order, registration or qualification of or
with any court or governmental agency or body, or any other person is
required for the issue and sale of the Shares or the consummation by
the Company of the transactions contemplated by this Agreement and the
Pricing Agreement except the registration under the 1933 Act of the
Shares and such consents, approvals authorizations, registrations, or
qualifications as may be required under state or foreign securities or
Blue Sky laws in connection with the purchase and distribution of the
Shares by the Underwriters.
14. There is no action, suit or proceeding before or by any court or
governmental agency or body, domestic or foreign, now pending, or, to
the knowledge of the Company, threatened, against or affecting the
Company or any Subsidiary, which is required to be disclosed in the
Registration Statement (other than as disclosed therein), or which
might result in any material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or
business prospects of the Company and its subsidiaries considered as
one enterprise, or which might materially and adversely affect the
properties or assets thereof or which might materially and adversely
affect the consummation of this Agreement; all pending legal or
governmental proceedings to which the Company or any Subsidiary is a
party or of which any of their respective property or assets is the
subject which are not described in the Registration Statement,
including ordinary routine litigation incidental to the business, are,
considered in the aggregate, not material; and there are no contracts
or documents of the Company or any Subsidiary which are required to be
filed as exhibits to the Registration Statement by the 1933 Act or by
the 1933 Act Regulations which have not been so filed.
15. The Company and the Subsidiaries have good and marketable
6
title to all of the properties and assets reflected in the financial
statements included in the Prospectus (or as described in the
Prospectus), subject to no lien, mortgage, pledge, charge or
encumbrance of any kind except those reflected in such financial
statements (or as described in the Prospectus) or which are not
material in amount. The Company and the Subsidiaries occupy their
leased properties, if any, under valid and binding leases conforming
to the description thereof set forth in the Prospectus.
16. Except as set forth in the Prospectus, no holder of any securities of
the Company has any rights to require the Company to register any
securities of the Company under the 1933 Act.
17. Other than this Agreement and the Pricing Agreement, the Company is
not a party to any contract, agreement or understanding with any
person that would give rise to a valid claim against the Company for a
brokerage commission, finder's fee or like payment in connection with
the sale of the Shares.
18. The Shares have been authorized for inclusion in the Nasdaq National
Market.
19. No statement, representation, warranty or covenant made by the Company
in any certificate or document required by this Agreement to be
delivered to the Underwriters was or will be, when made, inaccurate,
untrue or incorrect in any material respect.
20. Neither of the Company, nor any of its directors, officers or
controlling persons, has taken and will take, directly or indirectly,
any action resulting in a violation of Rule 10b-6 under the 1934 Act,
or designed to cause or result in or that has constituted or
reasonably might be expected to constitute, the stabilization or
manipulation of the price of any security of the Company to facilitate
the sale or resale of the Shares.
21. The Company and the Subsidiaries own or possess, or can acquire on
reasonable terms, the patents, patent rights, licenses, inventions,
copyrights, know-how (including trade secrets and other unpatentable
proprietary or confidential information, systems or procedures),
trademarks, service marks and trade names presently employed by them
in connection with the business now operated by them, and neither the
Company nor any of the Subsidiaries has received any notice of
infringement of or conflict with asserted rights of others with
respect to any of the foregoing which, singly or in the aggregate, if
the subject of an unfavorable decision, ruling or finding, would
result in any material adverse change in the condition, financial or
otherwise, or in the earnings, business affairs or business prospects
of the Company and the Subsidiaries considered as one enterprise.
22. The Company has obtained and delivered to the Underwriters the
agreements of the persons and entities named in Schedule B annexed
hereto to the effect that each such person or entity will not, for a
period of
7
365 days from the date hereof, without FBR's prior written consent,
directly or indirectly, offer to sell, sell, grant any option for the
sale of, or otherwise dispose of, any Common Stock of the Company or
any securities convertible into or exercisable for Common Stock of the
Company owned by such person or with respect to which such person has
the power of disposition.
(b) Any certificate signed by any officer or attorney-in-fact of the
Company, and delivered to the Representative or to counsel for the Underwriters
shall be deemed a representation and warranty by such entity to each Underwriter
as to the matters covered thereby.
I. Sale and Delivery to Underwriters; Closing; Reservation of Shares.
(a) On the basis of the representations and warranties herein contained and
subject to the terms and conditions herein set forth, the Company agrees to sell
the Firm Shares to each Underwriter, severally and not jointly, and each
Underwriter, severally and not jointly, agrees to purchase from the Company, at
the price per share set forth in the Pricing Agreement, the number of Firm
Shares set forth in Schedule A hereto opposite the name of such Underwriter
(except as otherwise provided in the Pricing Agreement), plus any additional
number of Firm Shares which such Underwriter may become obligated to purchase
pursuant to Section 9 hereof.
If the Company has elected not to rely upon Rule 430A under the 1933 Act
Regulations, the public offering price and the purchase price per share to be
paid by the Underwriter for the Shares have each been determined and set forth
in the Pricing Agreement, dated the date hereof, and an amendment to the
Registration Statement and the Prospectus reflecting such information will be
filed before the Registration Statement becomes effective.
If the Company has elected to rely upon Rule 430A under the 1933 Act
Regulations, the purchase price per share to be paid by the Underwriters for the
Shares shall be an amount equal to the initial public offering price, less an
amount per share to be determined by agreement between the Representative and
the Company. The initial public offering price per share of the Shares shall be
a fixed price to be determined by agreement between the Representative and the
Company. The public offering price and the purchase price, when so determined,
shall be set forth in the Pricing Agreement. In the event that such prices have
not been agreed upon and the Pricing Agreement has not been executed and
delivered by all parties thereto by the close of business on the fourth business
day following the date of this Agreement, this Agreement shall terminate
forthwith, without liability of any party to any other party hereunder other
than pursuant to Section 6 hereof, unless otherwise agreed to by the Company and
the Representative.
(b) In addition, on the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, the Company
hereby grants an option to the Underwriters to purchase up to an additional
________ shares of Common Stock, as Option Shares, at the price per share set
forth in the Pricing Agreement. The option hereby granted will expire 30 days
after the date hereof (or, if the Company has elected to rely upon Rule 430A
under the 1933 Act Regulations, 30 days after the Representation Date) and may
be exercised in whole or in part from time to time only for the purpose of
covering over-allotments which may be made in connection with the offering and
distribution of the Firm Shares upon notice by the Representative to the Company
setting forth the number of Option Shares as to which the Underwriters are then
exercising the option and the time, date and place of payment and delivery for
such Option Shares. Any such time and date of delivery (a "Date of Delivery")
shall be
8
determined by the Representative but shall not be later than seven full business
days after the exercise of said option nor in any event prior to Closing Time,
as hereinafter defined, unless otherwise agreed upon by the Representative and
the Company. If the option is exercised as to all or any portion of the Option
Shares, the Option Shares shall be purchased by the Underwriters, severally and
not jointly, in proportion to their respective Firm Share underwriting
obligations as set forth in Schedule A hereto (except as may be otherwise
provided in the Pricing Agreement).
(c) Payment of the purchase price for and delivery of certificates for the
Firm Shares shall be made at the offices of Xxxxxx & Xxxxxxx, 0000 Xxxxxxxxxxxx
Xxxxxx, X.X., Xxxxx 0000, Xxxxxxxxxx, D.C., or at such other place as shall be
agreed upon by the Representative and the Company, at 10:00 a.m. Washington,
D.C. time, on the ____ business day following the date the Registration
Statement becomes effective if the sale of the Shares is priced before 4:30 p.m.
Eastern time or on the ____ business day following the date the Registration
Statement becomes effective if the sale of the Shares is priced after 4:30 p.m.
Eastern time (or, if the Company has elected to rely upon Rule 430A, the ____
business day after the Representation Date or the ____ business day after the
Representation Date if the sale of the Shares is priced after 4:30 p.m. Eastern
time) or such other time not later than 10 business days after such date as
shall be agreed upon by the Representative and the Company (such time and date
of payment and delivery being herein called "Closing Time"). In addition, in the
event that any or all of the Option Shares are purchased by the Underwriters,
payment of the purchase price for and the delivery of such Option Shares shall
be made at the above-mentioned offices of Xxxxxx & Xxxxxxx, or at such other
place as shall be mutually agreed upon by the Representative and the Company, on
each Date of Delivery as specified in the notice from the Representative to the
Company. Payment shall be made to the Company by certified or official bank
check or checks in New York Clearing House or similar next day funds payable to
the order of the Company against delivery to the Representative for the
respective accounts of the Underwriters of certificates for the Shares to be
purchased by the Underwriters. The certificates for the Firm Shares and the
Option Shares shall be in such authorized denominations and registered in such
names as the Representative may request in writing at least two business days
before Closing Time or each Date of Delivery, as the case may be. It is
understood that each Underwriter has authorized FBR, for its account, to accept
delivery of, receipt for, and make payment of the purchase price for, the Shares
which it has agreed to purchase. FBR, individually and not as a Representative
of the Underwriters, may (but shall not be obligated to) make payment of the
purchase price for the Shares to be purchased by any Underwriter whose check has
not been received by Closing Time, but such payment shall not relieve such
Underwriter from its obligations hereunder. The certificates for the Firm Shares
and the Option Shares will be made available for examination and packaging by
the Underwriters not later than 10:00 a.m., Washington, D.C. time, on the last
business day prior to Closing Time or each Date of Delivery, as the case may be.
I. Covenants of the Company, the Operating Partnership and the Selling
Stockholder.
9
(a) The Company covenants with each Underwriter as follows:
1. The Company will (i) prepare the Prospectus in a form approved by the
Representative and file such Prospectus pursuant to Rule 424(b) of the
1933 Act Regulations not later than the Commission's close of business
on the second business day following the execution and delivery of
this Agreement, or, if applicable, such earlier time as may be
required by Rule 430A(a)(3) of the 1933 Act Regulations; (ii) advise
the Representative, promptly after it receives notice thereof, of the
time when the Registration Statement, or any amendment thereto, has
been filed or becomes effective or any supplement to the Prospectus or
any amended Prospectus has been filed; (iii) advise the
Representative, promptly after it receives notice thereof, of (A) the
receipt of any comments from the Commission, (B) the issuance by the
Commission of any stop order or of any order preventing or suspending
the use of any preliminary prospectus or the Prospectus, (C) the
suspension of the qualification of the shares for offering or sale in
any jurisdiction, (D) the initiation or threatening of any proceeding
for any such purpose, or (E) any request by the Commission for the
amending or supplementing of the Registration Statement or Prospectus
or for additional information; and, (iv) in the event of the issuance
of any stop order or any order preventing or suspending the use of any
Preliminary Prospectus or prospectus or suspending any such
qualification, to obtain its withdrawal at the earliest possible
moment.
2. The Company will (i) give the Representative notice of its intention
to prepare or file any amendment to the Registration Statement
(including any post-effective amendment) or any amendment or
supplement to the Prospectus (including any revised prospectus that
the Company proposes for use by the Underwriters in connection with
the offering of the Shares that differs from the prospectus on file at
the Commission at the time the Registration Statement becomes
effective, whether or not such revised prospectus is required to be
filed pursuant to Rule 424(b) of the 1933 Act Regulations), (ii)
furnish the Underwriters with copies of any such amendments or
supplements a reasonable time prior to the proposed filing or use
thereof, and (iii) not file any such amendment or any supplement or
use any such prospectus to which the Representative shall object.
3. Promptly from time to time, the Company will take such action as the
Representative may reasonably request to qualify the Shares for
offering and sale under the securities laws of such jurisdictions as
the Representative may request and to comply with such laws so as to
permit the continuance of sales and dealings therein in such
jurisdictions for as long as may be necessary to complete the
distribution of the Shares, provided that in
10
connection therewith the Company shall not be required to qualify as a
foreign correspondent in any jurisdiction.
4. The Company will furnish each Underwriter with copies of the
Prospectus in such quantities as such Underwriter may from time to
time request. If the delivery of a prospectus is required at any time,
prior to the expiration of nine months after the time of issue of the
Prospectus in connection with the offering or sale of the Shares, and
if at such time. any event shall have occurred as a result of which
the Prospectus as then amended or supplemented would include an untrue
statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the
circumstances under which they were made when such Prospectus is
delivered, not misleading, or, if for any other reason it shall be
necessary during such period to amend or supplement the Prospectus in
order to comply with the 1933 Act and the 1933 Act Regulations, the
Company will notify the Representative and upon the Representative'
request will prepare and furnish without charge to the Underwriters
and to any dealer in securities as many copies as the Underwriters may
from time to time reasonably request of an amended Prospectus or a
supplement to the Prospectus which will correct such statement or
omission or effect such compliance. In case the Underwriters are
required to deliver a prospectus in connection with sales of any of
the Shares at any time nine months or more after the time of issue of
the Prospectus, upon the Underwriter's request but at the
Underwriter's expense, the Company will prepare and deliver to the
Underwriters as many copies as the Underwriters may request of an
amended or supplemented Prospectus complying with Section 10(a)(3) of
the 1933 Act.
5. The Company will make generally available to its security holders as
soon as practicable, but not later than 60 days after the close of the
period covered thereby, an earnings statement (in form complying with
the provisions of Rule 158 of the 1933 Act Regulations) covering a
twelve month period beginning not later than the first day of the
Company's fiscal quarter next following the "effective date" (as
defined in said Rule 158) of the Registration Statement.
6. The Company will furnish to its stockholders, as soon as practicable
after the end of each fiscal year, an annual report (including a
balance sheet and statements of income, stockholders' equity and cash
flow of the Company and its consolidated subsidiaries certified by
independent public accountants) and, as soon as practicable after the
end of each of the first three quarters of each fiscal year (beginning
with the fiscal quarter ending after the effective date of the
Registration Statement), consolidated summary financial information of
the Company and its subsidiaries for such quarter in reasonable
detail.
11
7. During a period of five years from the effective date of the
Registration Statement, the Company will furnish to the Representative
copies of all reports or other communications (financial or other)
furnished to stockholders, and deliver to the Representative, as soon
as they are available, copies of any reports and financial statements
furnished to or filed with the Commission or any national securities
exchange or quotation system on which any class of securities of the
Company is listed.
8. The Company will use the net proceeds of the sale of the Firm Shares
and Option Shares for the purposes described in the Prospectus under
"Use of Proceeds."
9. The Company will take all action to ensure that the Common Stock
continues to be listed on the Nasdaq National Market or any national
securities exchange.
10. Except for the authorization of actions permitted to be taken by the
Underwriters as contemplated herein or in the Prospectus, the Company
will not (A) take, directly or indirectly, any action designed to
cause or to result in, or that might reasonably be expected to
constitute, the stabilization or manipulation of the price of any
security of the Company to facilitate the sale or resale of the
Shares, (B) sell, bid for or purchase the Shares or pay any person any
compensation for soliciting purchases of the Shares, or (C) pay or
agree to pay to any person any compensation for soliciting another to
purchase any other securities of the Company.
11. During the period from the date of the Pricing Agreement until 365
days after Closing Time, the Company will not, without the prior
written consent of FBR, directly or indirectly, sell, offer to sell,
grant any option for the sale of, or otherwise dispose of, any Common
Stock or any other security convertible into or exchangeable into or
exercisable for Common Stock, otherwise than (A) in accordance with
this Agreement, (B) in connection with the Company's stock option plan
as presently in effect, (C) upon exercise of the Warrants or (D) as
otherwise contemplated in the Prospectus.
12. The Company confirms as of the date hereof that it is in compliance
with all provisions of Section 1 of Laws of Florida, Chapter 92- 198.
13. The Company will file with the Commission such reports on Form SR as
may be required pursuant to Rule 463 under the 1933 Act.
I. Payments of Fees and Expenses.
The Company covenants and agree with the Underwriters that the Company will
pay all expenses incident to the performance of its obligations under this
Agreement, including: (i) the printing and filing of the Registration Statement
as originally filed and of each amendment thereto, (ii) the preparation,
issuance and delivery of the certificates for the Shares to the Underwriters,
(iii)
12
the fees and other charges of the Company's counsel and accountants, (iv) the
qualification of the Shares under securities laws in accordance with the
provisions of Section 3(a)(iii) hereof, including filing fees and the fees and
other charges of counsel for the Underwriters in connection therewith and in
connection with the preparation of the Blue Sky Memorandum, (v) the printing and
delivery to the Underwriters of copies of the Registration Statement as
originally filed and of each amendment thereto, of the preliminary prospectuses,
and of the Prospectus and any amendments or supplements thereto, (vi) the
printing and delivery to the Underwriters of copies of the Blue Sky Memorandum;
(vii) the fee of the NASD, including the reasonable fees and other charges of
counsel for the Underwriters in connection with the NASD's review of the terms
of the proposed public offering of the Shares, (viii) the fees and expenses
incurred in connection with the listing of the Common Stock on the Nasdaq
National Market, including filing and listing fees, and (ix) all out-of-pocket
expenses of the Underwriters, including fees and disbursements of counsel,
incurred by the Underwriter in making preparations for the offering, purchase,
sale and delivery of the Shares and in connection with their services rendered
pursuant to the Engagement Letter (as defined below).
If this Agreement is canceled or terminated by the Representative in
accordance with the provisions of Sections 5 or 8 hereof, the Company also shall
reimburse the Underwriters for its out-of-pocket expenses, including the fees
and other charges of counsel for the Underwriters.
I. Conditions of Underwriters' Obligations
The obligations of the Underwriters hereunder, as to the Shares to be
delivered at each Date of Delivery, shall be subject to the condition that all
representations and warranties and other statements of the Company, herein are,
at and as of such Date of Delivery, true and correct, the condition that the
Company, shall have performed all of its obligations hereunder theretofore to be
performed, and the following additional conditions:
(a) The Registration Statement shall have become effective not later than
10:00 a.m. Eastern time on the first business day following the date hereof, no
stop order suspending the effectiveness of the Registration Statement or any
part thereof shall have been issued and no proceeding for that purpose shall
have been initiated or threatened by the Commission; and all requests for
additional information on the part of the Commission shall have been complied
with to the Representative' reasonable satisfaction. If the Company has elected
to rely upon Rule 430A of the 1933 Act Regulations, the price of the Shares and
any price-related information previously omitted from the effective Registration
Statement pursuant to such Rule 430A shall have been transmitted to the
Commission for filing pursuant to Rule 424(b) of the 1933 Act Regulations within
the applicable time period prescribed for such filing by the 1933 Act
Regulations and in accordance with Section 3(a) hereof, or a post-effective
amendment providing such information shall have been promptly filed and declared
effective in accordance with the requirements of Rule 430A of the 1933 Act
Regulations.
(b) At Closing Time the Representative shall have received:
(1) The favorable opinion, dated as of Closing Time, of Wyrick,
Robbins, Xxxxx & Xxxxxx, L.L.P., counsel for the Company, in form and substance
satisfactory to counsel for the Underwriters, to the effect that:
13
1. The Company has been duly incorporated and is validly existing as a
corporation in good standing under the laws of State of Delaware.
2. The Company has corporate power and authority to own, lease and
operate its properties and to conduct its business as described in the
Registration Statement.
3. The Company is duly qualified as a foreign corporation to transact
business and is in good standing in each jurisdiction in which such
qualification is required.
4. The authorized, issued and outstanding capital stock of the Company is
as set forth in the Prospectus under "Capitalization", and the shares
of issued and outstanding Common Stock have been duly authorized and
validly issued and are fully paid and non-assessable.
5. The Shares have been duly authorized for issuance and sale to the
Underwriters pursuant to this Agreement and, when issued and delivered
by the Company pursuant to this Agreement against payment of the
consideration set forth in the Pricing Agreement, will be validly
issued and fully paid and non-assessable.
6. The issuance of the Shares is not subject to preemptive or other
similar rights arising by operation of law or to the best of their
knowledge and information, otherwise.
7. Each subsidiary of the Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of
the jurisdiction of its incorporation, has corporate power and
authority to own, lease and operate its properties and to conduct its
business as described in the Registration Statement and, to the best
of their knowledge and information, is duly qualified as a foreign
corporation to transact business and is in good standing in each
jurisdiction in which such qualification is required; all of the
issued and outstanding capital stock of each such subsidiary has been
duly authorized and validly issued, is fully paid and non-assessable
and, to the best of their knowledge and information, is owned by the
Company, directly or through subsidiaries, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, claim or
equity.
8. This Agreement and the Pricing Agreement have been duly authorized,
executed and delivered by the Company.
9. The Registration Statement is effective under the 1933 Act and, to the
best of their knowledge and information, no stop order suspending the
effectiveness of the Registration Statement has been issued under the
1933 Act or proceedings therefor initiated or threatened by the
Commission.
10. At the time the Registration Statement became effective and
14
at the Representation Date, the Registration Statement (other than the
financial statements and supporting schedules included therein, as to
which no opinion need be rendered) complied as to form in all material
respects with the requirements of the 1933 Act and the 1933 Act
Regulations.
11. The Common Stock conforms to the description thereof contained in the
Prospectus, and the form of certificate used to evidence the Common
Stock is in due and proper form and complies with all applicable
statutory requirements.
12. To the best of their knowledge and information, there are no legal or
governmental proceedings pending or threatened which are required to
be disclosed in the Registration Statement, other than those disclosed
therein, and all pending legal or governmental proceedings to which
the Company or any subsidiary is a party or to which any of their
property is subject which are not described in the Registration
Statement, including ordinary routine litigation incidental to the
business, are, considered in the aggregate, not material.
13. The information in the Prospectus to the extent that it constitutes
matters of law, summaries of legal matters, documents or proceedings,
or legal conclusions, has been reviewed by them and is correct in all
material respects.
14. To the best of their knowledge and information, there are no
contracts, indentures, mortgages, loan agreements, notes, leases or
other instruments required to be described or referred to in the
Registration Statement or to be filed as exhibits thereto other than
those described or referred to therein or filed as exhibits thereto,
the descriptions thereof or references thereto are correct, and no
default exists in the due performance or observance of any material
obligation, agreement, covenant or condition contained in any
contract, indenture, mortgage, loan agreement, note, lease or other
instrument so described, referred to, or filed.
No authorization, approval, consent or order of any court or governmental
authority or agency is required in connection with the sale of the Shares to the
Underwriters, except such as may be required under the 1933 Act, the 1933 Act
Regulations or state securities law; and, to the best of their knowledge and
information, the execution and delivery of the Agreement and the Pricing
Agreement and the consummation of the transactions contemplated herein and
therein will not conflict with or constitute a breach of, or default under,
result in the creation or imposition of any lien, charge or encumbrance upon any
property or assets of the Company or any of its subsidiaries pursuant to, any
contract, indenture, mortgage, loan agreement, note, lease or other instrument
to which the Company or any of its subsidiaries is a party by which it or any of
them may be bound, or to which any of the property or assets of the Company or
any of its subsidiaries is subject, nor will such action result in any violation
of the provisions of the charter or by-laws of the Company, or any applicable
law, administrative regulation or court decree.
15
In rendering such opinions, such counsel may set forth the scope of the
factual investigation conducted (which may be reasonable limited to the extent
acceptable to counsel to the Underwriters) and may state as to matters of fact
that such counsel is relying exclusively, without independent investigation or
review, on one or more certificates of public officials, governmental agencies
or departments or officers of the Company provided that counsel shall state that
it knows of no reason why such reliance is not reasonable.
In giving the opinion required by this Section 5(b), Wyrick, Robbins, Xxxxx
& Xxxxxx L.L.P. shall additionally state they have participated in the
preparation of the Registration Statement and the Prospectus, and in conferences
with officers and other representatives of the Company, and representatives of
the independent public accountants for the Company, and that, while they have
not undertaken to determine independently, and do not assume any responsibility
for, the accuracy, completeness, or fairness of the statements in the
Registration Statement or Prospectus, on the basis of the foregoing no facts
have come to their attention which causes them to believe that (i) the
Registration Statement (except for the financial statements and schedules
thereto and other financial and statistical information and data included
therein or omitted therefrom, as to which such counsel need express no opinion),
at the time the Registration Statement became effective, contained an untrue
statement of a material fact or omitted to state a material fact required to be
stated therein or necessary to make the statements therein in light of the
circumstances under which they were made, not misleading, or that the
Prospectus, as of the date of such opinion (except as aforesaid), contained an
untrue statement of a material fact or omits to state a material fact necessary
in order to make, not misleading, (ii) there are any legal or governmental
proceedings pending or threatened against the Company that are required to be
disclosed in the Registration Statement or the Prospectus (except for the
financial statements and schedules thereto, as to which such counsel need
express no opinion), other than those disclosed therein or (iii) there are any
contracts or documents of a character required to be described in the
Registration Statement or the Prospectus or to be filed as exhibits to the
Registration Statement that are not described or referred to therein or so
filled.
In basing their opinion and other matters set forth therein on "knowledge"
or other words to that effect, such phrase shall mean the actual knowledge
(i.e., the conscious awareness of facts or other information) of lawyers in the
firm who have given substantive legal attention to representing the Company or
its affiliates in connection with this Agreement and the transactions
contemplated thereunder.
(2) The favorable opinion, dated as of Closing Time, of Xxxxxx & Xxxxxxx,
counsel for the Underwriters, with respect to such matters as the Representative
may reasonably request.
(c) At Closing Time there shall have been, since the date hereof or since
the respective dates as of which information is given in the Registration
Statement and the Prospectus, any material adverse change in the condition,
financial or otherwise, or in the earnings, business affairs or business
prospects of the Company and its
16
subsidiaries considered as one enterprise, whether or not arising in the
ordinary course of business, and the Representative shall have received a
certificate of the President or a Vice President of the Company, dated as of
Closing Time, to the effect that (i) there has been no such material adverse
change, (ii) the representations and warranties in Section 1 are true and
correct with the same force and effect as though expressly made at and as of
Closing Time, (iii) the Company has complied with all agreements and satisfied
all conditions on its part to be performed or satisfied at or prior to Closing
Time, and (iv) no stop order suspending the effectiveness of the Registration
Statement has been issued and no proceedings for that purpose have been
initiated or threatened by the Commission.
(d) At the time of the execution of this Agreement and on the effective
date of the most recently filed post-effective amendment to the Registration
Statement and also at each Date of Delivery, Ernst & Young LLP shall have
furnished to the Representative a letter or letters, dated the respective date
of delivery thereof, in form and substance satisfactory to the Representative,
to the effect set forth in Annex I hereto and, if the Company has elected to
rely upon Rule 430A of the 1933 Act Regulations, to the further effect that they
have carried out procedures specified in paragraph (v) of Annex I with respect
to certain amounts, percentages, and financial information specified by the
Representative and deemed to be part of the Registration Statement pursuant to
Rule 430A(b) and have found such amounts, percentages and financial information
to be in agreement with the records specified in such paragraph (v).
(e) At Closing Time and at each Date of Delivery, if any, counsel for the
Underwriters shall have been furnished with such documents and opinions as they
may require for the purpose of enabling them to pass upon the issuance and sale
of the Shares as herein contemplated and related proceedings, or in order to
evidence the accuracy of any of the representations or warranties, or the
fulfillment of any of the conditions, herein contained; and all proceedings
taken by the Company in connection with the issuance and sale of the Shares as
herein contemplated shall be satisfactory in form and substance to the
Representative and counsel for the Underwriters.
(f) In the event that the Underwriters exercise their option provided in
Section 2(b) hereof to purchase all or any portion of the Option Shares, the
representations and warranties of the Company contained herein and the
statements in any certificates furnished by the Company hereunder shall be true
and correct as of each Date of Delivery and, at the relevant Date of Delivery,
the Representative shall have received:
(1) A certificate, dated such Date of Delivery, of the President or a Vice
President of the Company and of the chief financial or chief accounting officer
of the Company confirming that the certificate delivered at the Closing Time
pursuant to Section 5(c) hereof remains true and correct as of such Date of
Delivery.
(2) The favorable opinion of Wyrick, Robbins, Xxxxx & Xxxxxx, L.L.P.,
counsel for the Company, in form and substance satisfactory to counsel for the
Underwriters, dated such Date of Delivery, relating to the Option Securities to
be purchased on such Date of Delivery and otherwise to the same effect as the
opinion required by Sections 5(b)(1) and 5(b)(3) hereof.
(3) The favorable opinion of Xxxxxx & Xxxxxxx, counsel for the
Underwriters, dated such Date
17
of Delivery, relating to the Option Securities to be purchased on such Date of
Delivery and otherwise to the same effect as the opinion required by Sections
5(b)(2) and 5(b)(3) hereof.
(4) A letter from Ernst & Young, L.L.P., in form and substance satisfactory
to the Representative and dated such Date of Delivery, substantially the same in
form and substance as the letter furnished to the Representative pursuant to
Section 5(d) hereof, except that the "specified date" in the letter furnished
pursuant to this Section 5(f)(4) shall be a date not more than five days prior
to such Date of Delivery.
If any condition specified in this Section shall not have been fulfilled
when and as required to be fulfilled, this Agreement may be terminated by the
Representative by notice to the Company at any time at or prior to Closing Time,
and such termination shall be without liability of any party to any other party
except as provided in Section 4.
I. Indemnification.
(a) The Company hereby indemnifies and will hold harmless each Underwriter
and each person, if any, who controls any Underwriter within the meaning of
Section 15 of the 1933 Act, against any losses, claims, damages, or liabilities
(or actions in respect thereof) to which any Underwriter or such controlling
person may become subject, under the 1933 Act or otherwise, insofar as such
losses, claims, damages, or liabilities (or actions in respect thereof) arise
out of or are based upon an untrue statement or alleged untrue statement of a
material fact contained in any preliminary prospectus, the Registration
Statement, or the Prospectus, or any amendment or supplement thereto, or arise
out of or are based upon the omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, and will reimburse the Underwriters and such controlling
persons for any legal or other expenses reasonably incurred by the Underwriters
or such controlling persons in connection with investigating or defending any
such action or claim as such expenses are incurred.
(b) Each Underwriter severally agrees to indemnify and hold harmless the
Company, against any losses, claims, damages or liabilities to which the Company
may become subject insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon an untrue statement
or alleged untrue statement of a material fact contained in any part of the
Registration Statement or the Prospectus when such part became effective or
arise out of or are based upon the omission or alleged omission to state therein
a material fact required to be stated therein or necessary to make the
statements therein not misleading, in each case to the extent, but only to the
extent, that such untrue statement or alleged untrue statement or omission or
alleged omission was made therein in reliance upon and in conformity with
written information relating to such Underwriter and furnished to the Company by
such Underwriter, specifically for use in the preparation thereof.
(c) Promptly after receipt by an indemnified party under subsection 6(a) or
(b) above of notice of the commencement of any action, such indemnified party
shall, if a claim in respect thereof is to be made against the indemnifying
party under such subsection, notify the indemnifying party in writing of the
commencement thereof, but the omission so to notify the indemnifying party shall
not relieve the indemnifying party of its obligations thereunder unless the
failure to give such notice materially prejudices the indemnifying party's
ability to defend such matter. In case any such action shall be brought against
any indemnified party and it shall notify the indemnifying party of the
commencement thereof, the indemnifying party shall be entitled to participate
therein and, to the extent that it shall wish, jointly with any other
indemnifying party similarly notified, to assume the defense thereof, with
counsel reasonably satisfactory to such indemnified party (who shall not, except
with the consent of the indemnified party, be counsel to the indemnifying
party), and, after notice from the indemnifying party to such indemnified party
of its election so to assume the defense thereof, the indemnifying party shall
not be liable to such indemnified party under such subsection for any legal
expenses of other counsel or any other expenses, in each case subsequently
incurred by such indemnified party, in connection with the defense thereof other
than reasonable costs of investigation, unless such indemnified party reasonably
objects to such assumption on the ground that the named parties to any such
action
18
(including any impleaded parties) include both such indemnified party and an
indemnifying party and such indemnified party reasonably believes that there may
be legal defenses available to it that are different from or in addition to
those available to such indemnifying party. In no event shall the indemnifying
parties be liable for fees and expenses of more than one counsel (in addition to
local counsel) separate from their own counsel for all indemnified parties in
connection with any one action or separate but similar related actions in the
same jurisdiction arising out of the same general allegations or circumstances.
(d) If the indemnification provided for in this Section 6 is unavailable
to, or insufficient to hold harmless, an indemnified party under subsection 6(a)
or (b) above in respect of any losses, claims, damages or liabilities (or
actions in respect thereof referred to therein, then each indemnifying party
shall contribute to the amount paid or payable by such indemnified party as a
result of such losses, claims, damages or liabilities (or actions in respect
thereof) in such proportion as is appropriate to reflect the relative benefits
received by the Company, on the one hand and the Underwriters on the other from
the offering of the Shares. If, however, the allocation provided by the
immediately preceding sentence is not permitted by applicable law or if the
indemnified party failed to give the notice required under subsection 6(c)
above, then each indemnifying party shall contribute to such amount paid or
payable by such indemnified party in such proportion as is appropriate to
reflect not only such relative benefits but also the relative fault of the
Company, on the one hand and the Underwriters on the other in connection with
the statements or omissions which resulted in such losses , claims, damages or
liabilities (or actions in respect thereof), as well as any other relevant
equitable considerations. The relative benefits received by the Company, on the
one hand and the Underwriters on the other shall be deemed to be in the same
proportion as the total net proceeds from the offering of the Shares purchased
under this Agreement (before deducting expenses) received by the Company, bear
to the total underwriting discounts and commissions received by the Underwriters
with respect to the Shares purchased under this Agreement, in each case as set
forth in the table on the cover page of the Prospectus. The relative fault shall
be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information supplied by the Company, on the one hand
or the Underwriters on the other and the parties' relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission. The Company, and the Underwriters agree that it would not be just and
equitable if contributions pursuant to this subsection 6(d) were determined by
pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation which does not take account
of the equitable considerations referred to above in this subsection 6(d). The
amount paid or payable by an indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to above
in this subsection 6(d) shall be deemed to include any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the 0000 Xxx) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.
(e) The obligations of the Company, under this Section 6 shall be in
addition to any liability which the Company, may otherwise have and shall
extend, upon the same terms and conditions, to each person, if any, who controls
the Underwriters within the meaning of the 1933 Act; and the obligations of the
Underwriters under this Section 6 shall be in addition to any liability which
the Underwriters may otherwise have and shall extend, upon the same terms and
conditions, to each officer and director of the Company (including any person
who, with his or her consent, is named in the Registration Statement as about to
become a director of the Company) and to each person, if any, who controls the
Company, within the meaning of the 1933 Act.
(f) The provisions of this Section 6 shall supersede the indemnification
provisions included in the letter agreement dated July ___, 1996 among the
Underwriters, on the one hand, and the Company, on the other hand (the
"Engagement Letter"), insofar, but only insofar, as such indemnification
provisions relate to any such loss, claim, damage or liability that arises out
of is based upon an untrue statement or alleged untrue statement or omission or
alleged omission made in any preliminary prospectus, the Registration Statement
or the Prospectus or any amendment or supplement thereto. In all other respects,
the provisions of the Engagement Letter shall remain in full force and
19
effect.
I. Representations, Warranties and Agreements to Survive Delivery.
The respective indemnities, agreements, representations, warranties and
other statements of the Company, and the Underwriters, as set forth in this
Agreement and the Pricing Agreement or made by or on behalf of them,
respectively, pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation (or any statement as to the results thereof)
made by or on behalf of the Underwriters or any controlling person of the
Underwriters, or the Company or any officer or director or controlling person of
the Company and shall survive delivery of and payment for the Shares.
I. Termination of Agreement.
(a) The Representative may terminate this Agreement, by notice to the
Company and the Selling Shareholders at any time at or prior to Closing Time (i)
if there has been, since the date of this Agreement or since the respective
dates as of which information is given the Registration Statement, any material
adverse change in the condition, financial or otherwise, or in the earnings,
business affairs or business prospects of the Company and its subsidiaries
considered as one enterprise, whether or not arising in the ordinary course of
business, or (ii) if there has occurred any outbreak of hostilities or
escalation thereof or other calamity or crisis, the effect of which on the
financial markets of the United States is such as to make it, in the judgment of
the Representative, impracticable to market the Shares or to enforce contracts
for the sale of the Shares, or (iii) if trading generally on either the American
Stock Exchange or the New York Stock Exchange has been suspended, or minimum or
maximum prices for trading have been fixed, or maximum ranges for prices for
securities have been required, by either of said Exchanges or by order of the
Commission or any other governmental authority, or if banking moratorium has
been declared by either Federal, New York or Virginia authorities.
(b) If this Agreement is terminated pursuant to this Section, such
termination shall be without liability of any party to any other party except as
provided in Section 4. Notwithstanding any such termination, the provisions of
Section 6 shall remain in effect.
I. Default by One or More of the Underwriters.
If one or more of the Underwriters shall fail at Closing Time to purchase
the Shares which it or they are obligated to purchase under this Agreement and
the Pricing Agreement (the "Defaulted Shares"), the Representative shall have
the right, within 24 hours thereafter, to make arrangements for one or more of
the non-defaulting Underwriters, or any other underwriters, to purchase all, but
not less than all, of the Defaulted Shares in such amounts as may be agreed upon
and upon the terms herein set forth; if, however, the Representative shall not
have completed such arrangements within such 24-hour period, then: (a) if the
number of Defaulted Shares does not exceed ten percent (10%) of the Shares, the
non-defaulting Underwriters shall be obliged to purchase the full amount thereof
in the proportions that their respective underwriting obligations hereunder bear
to the underwriting obligations of all non-defaulting Underwriters; or (b) if
the number of Defaulted Shares exceeds ten percent (10%) of the Shares, this
Agreement shall terminate without liability on the part
20
of any non-defaulting Underwriter.
No action taken pursuant to this Section 9 shall relieve any defaulting
Underwriter from liability in respect of its default.
In the event of any such default which does not result in a termination of
this Agreement, the Representative and the Company each shall have the right to
postpone the Closing Time for a period not exceeding seven days in order to
effect any required changes in the Registration Statement or Prospectus or in
any other documents or arrangements.
I. Notices.
All statements, requests, notices and agreements hereunder shall be in
writing, and, if to the Underwriters, shall be delivered or sent by mail or
facsimile transmission to Friedman, Billings, Xxxxxx & Co., Inc., 0000
Xxxxxxxxxx Xxxxxx Xxxxx, Xxxxxxxxx, Xxxxxxxx 00000, Attention: Xxxxxxx Xxxxxxxx;
if to the Company, shall be delivered or sent by mail or facsimile transmission
to the address of the Company set forth in the Registration Statement,
Attention: Xxx X. Xxxxxx. Any such statements, requests, notices or agreements
shall take effect at the time of receipt thereof.
I. Parties.
This Agreement and the Pricing Agreement shall be binding upon, and inure
solely to the benefit of, (i) the Underwriters and the Company and (ii) to the
extent provided in Sections 6 and 7 hereof, the officers and directors of the
Company, and each person who controls the Company or the Underwriters, and their
respective heirs, executors, administrators, successors and assigns, and no
other person shall acquire or have any right under or by virtue of this
Agreement or the Pricing Agreement. No purchaser of any of the Shares from the
Underwriters shall be deemed a successor or assign merely by reason of such
purchase.
I. Time of Essence.
Time shall be of the essence of this Agreement and the Pricing Agreement.
As used herein, the term "business day" shall mean any day when the Commission's
office in Washington, D.C. is open for business.
I. Choice of Law.
This Agreement and the Pricing Agreement shall be governed by and construed
in accordance with the laws of the State of New York.
I. Counterparts.
21
This Agreement may be executed by any one or more of the parties hereto in
any number of counterparts, each of which shall be deemed to be an original, but
all such counterparts shall together constitute one and the same instrument.
22
If the foregoing is in accordance with your understanding, please sign and
return to us four counterparts hereof, and, upon the acceptance hereof by the
Underwriters, this letter and such acceptance hereof shall constitute a binding
agreement between the Underwriters and the Company.
Very truly yours,
UOL PUBLISHING, INC.
CONFIRMED AND ACCEPTED,
as of the date first above written: By: ___________________________
Name:
FRIEDMAN, BILLINGS, XXXXXX Title:
& CO., INC.
By: __________________________
Name:
Title:
For itself and as Representative of the
other Underwriters named in Schedule
A hereto.
SCHEDULE A
Number of Shares
Underwriter to be Purchased
----------- ------------------
Friedman, Billings, Xxxxxx & Co., Inc...................
------------------
Total................................................... -
==================
ANNEX I
Pursuant to Section 5(d) of the Purchase Agreement, the accountants shall
furnish letters to the Representative to the effect that:
1. They are independent certified public accountants with respect to
the Company and its subsidiaries within the meaning of the 1933 Act and the
applicable rules and regulations thereunder.
2. In their opinion, the financial statements and any supplemental
financial information and schedules audited (and, if applicable, and/or pro
forma financial information examined) by them and included in the
Prospectus or the Registration Statement comply as to form in all material
respects with the applicable accounting requirements of the 1933 Act and
the related published rules and regulations thereunder; and, if applicable,
they have made a review in accordance with standards established by the
American Institute of Certified Public Accountants of the unaudited
consolidated interim financial statements as indicated in their reports
thereon, copies of which have been furnished to the Underwriters;
3. The unaudited selected financial information with respect to the
consolidated results of operations and financial position of the Company
for the five recent fiscal years included in the Prospectus agrees with the
corresponding amounts (after restatements where applicable) in the audited
consolidated financial statements for such five fiscal years for such
fiscal years;
4. On the basis of limited procedures, not constituting an audit in
accordance with generally accepted auditing standards, consisting of a
reading of the unaudited financial statements and other information
referred to below, a reading of the latest available interim financial
statements of the Company and its subsidiaries, inspection of the minute
books of the Company and its subsidiaries, inspection of the minute books
of the Company and its subsidiaries since the date of the latest audited
financial statements included in the Prospectus, inquiries of officials of
the Company and its subsidiaries responsible for financial and accounting
matters and such other inquiries and procedures as may be specified in such
letter, nothing came to their attention that caused them to believe that:
a. the unaudited consolidated statements of income, consolidated
balance sheets and consolidated statements of cash flows included in
the Prospectus do not comply as to form in all material respects with
the applicable accounting requirements of the 1933 Act and the related
published rules and regulations thereunder, or are not
1
in conformity with generally accepted accounting principles applied on
a basis substantially consistent with the basis for the audited
consolidated statements of income, consolidated balance sheets and
consolidated statements of cash flows included in the Prospectus;
b. any other unaudited income statement data and balance sheet
items included in the Prospectus do not agree with the corresponding
items in the unaudited consolidated financial statements from which
such data and items were derived, and any such unaudited data and
items were not determined on a basis substantially consistent with the
basis for the corresponding amounts in the audited consolidated
financial statements included in the Prospectus;
c. the unaudited financial statements which were not included in
the Prospectus but from which were derived any unaudited condensed
financial statements referred to in Clause (A) and any unaudited
income statement data and balance sheet items included in the
Prospectus and referred to in Clause (B) were not determined on a
basis substantially consistent with the basis for the audited
consolidated financial statements included in the Prospectus;
d. as of a specified date not more than five days prior to the
date of such letter, there have been any changes in the consolidated
capital stock (other than issuances of capital stock upon exercise of
options and stock appreciation rights, upon earn-outs of performance
shares and upon conversions of convertible securities, in each case
which were outstanding on the date of the latest financial statements
included in the Prospectus) or any increase in the consolidated
long-term debt of the Company and its subsidiaries, or any decreases
in consolidated net current assets or other items specified by the
Underwriters or any increases in any items specified by the
Underwriters, in each case as compared with amounts shown in the
latest balance sheet included in the Prospectus, except in each case
for changes, increases or decreases which the Prospectus discloses
have occurred or may occur or which are described in such letter; and
e. for the period from the date of the latest financial
statements included in the Prospectus to the specified date referred
to in Clause (D) there were any decreases in consolidated net revenues
2
or operating profit or the total or per share amounts of consolidated
net income or other items specified by the Underwriters, or any
increases in any items specified by the Underwriters, in each case as
compared with the comparable period of the preceding year and with any
other period of corresponding length specified by the Underwriters,
except in each case for decreases or increases which the Prospectus
discloses have occurred or may occur or which are described in such
letter; and
5. In addition to the audit referred to in their report(s) included in the
Prospectus and the limited procedures, inspection of minute books, inquiries and
other procedures referred to in paragraphs (iii) and (iv) above, they have
carried out certain specified procedures, not constituting an audit in
accordance with generally accepted auditing standards, with respect to certain
amounts, percentages and financial information specified by the Underwriters,
which are derived from the general accounting records of the Company and its
subsidiaries, which appear in the Prospectus, or in Part II of, or in exhibits
and schedules to the Registration Statement specified by the Underwriters, and
have compared certain of such amounts, percentages and financial information
with the accounting records of the Company and its subsidiaries and have found
them to be in agreement.
3
UOL PUBLISHING, INC.
_________ SHARES
COMMON STOCK
PRICING AGREEMENT
October ___, 1996
FRIEDMAN, BILLINGS, XXXXXX & CO., INC.
as Representative of the several Underwriters
c/o Friedman, Billings, Xxxxxx & Co., Inc.
0000 Xxxxxxxxxx Xxxxxx Xxxxx
Xxxxxxxxx, Xxxxxxxx 00000
Dear Sirs:
Reference is made to the Purchase Agreement, dated ______________, 1996
(the "Purchase Agreement"), relating to the purchase by the several Underwriters
named in Schedule A thereto, for whom FBR is acting as Representative (the
"Shares"), of UOL Publishing, Inc. (the "Company"). Capitalized terms not
otherwise defined herein shall bear the same meanings as given to them in the
Purchase Agreement.
Pursuant to Section 2 of the Purchase Agreement, the Company agrees with
each Underwriter as follows:
(1) The initial public offering price per share for the Shares, determined
as provided in Section 2, shall be $_________________.
(2) The purchase price per share for the Shares to be paid by the several
Underwriters shall be $___________, being an amount equal to the initial public
offering price set forth above less $__________ per Share; provided that the
purchase price per Share for any Option Share (as defined in the Purchase
Agreement) purchased upon exercise of the over-allotment option described in
Section 2(b) of the Purchase Agreement shall be reduced by an amount per share
equal to any dividends declared by the Company and payable on the Firm Shares
(as defined in the Purchase Agreement) but not payable on the Option Shares.
1
If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Company a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement among
the Underwriters and the Company in accordance with its terms.
Very truly yours,
UOL PUBLISHING, INC.
CONFIRMED AND ACCEPTED,
as of the date first above written: By: ______________________________
Name:
FRIEDMAN, BILLINGS, XXXXXX Title:
& CO., INC.
By: __________________________
Name:
Title:
For itself and as Representative of the other Underwriters named in Schedule A
to the Purchase Agreement.
